Weller M - Search Results

1

Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?

Naumann U, Durka S, Weller M. Naumann U, et al. Among authors: weller m. Oncogene. 1998 Sep 24;17(12):1567-75. doi: 10.1038/sj.onc.1202071. Oncogene. 1998. PMID: 9794234

2

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

Roth W, Fontana A, Trepel M, Reed JC, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Cancer Immunol Immunother. 1997 Mar;44(1):55-63. doi: 10.1007/s002620050355. Cancer Immunol Immunother. 1997. PMID: 9111585 Free PMC article.

3

Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?

Weller M, Schmidt C, Roth W, Dichgans J. Weller M, et al. Neurology. 1997 Jun;48(6):1704-9. doi: 10.1212/wnl.48.6.1704. Neurology. 1997. PMID: 9191791

4

Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.

Wagenknecht B, Gulbins E, Lang F, Dichgans J, Weller M. Wagenknecht B, et al. Among authors: weller m. FEBS Lett. 1997 Jun 2;409(1):17-23. doi: 10.1016/s0014-5793(97)00468-7. FEBS Lett. 1997. PMID: 9199495 Free article.

5

Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.

Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH, Weller M. Zipp F, et al. Among authors: weller m. J Immunol. 1997 Sep 1;159(5):2108-15. J Immunol. 1997. PMID: 9278296

6

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.

Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajewski S, Reed JC. Weller M, et al. Neurol Res. 1997 Oct;19(5):459-70. Neurol Res. 1997. PMID: 9329022

7

A new look at the role of p53 in leukemia cell sensitivity to chemotherapy.

Trepel M, Scheding S, Groscurth P, Horny HP, Malipiero U, Brugger W, Dichgans J, Weller M. Trepel M, et al. Among authors: weller m. Leukemia. 1997 Nov;11(11):1842-9. doi: 10.1038/sj.leu.2400824. Leukemia. 1997. PMID: 9369416

8

Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.

Weller M, Winter S, Schmidt C, Esser P, Fontana A, Dichgans J, Groscurth P. Weller M, et al. Int J Cancer. 1997 Nov 27;73(5):707-14. doi: 10.1002/(sici)1097-0215(19971127)73:5<707::aid-ijc16>3.0.co;2-2. Int J Cancer. 1997. PMID: 9398050

9

Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.

Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Br J Cancer. 1998;77(3):404-11. doi: 10.1038/bjc.1998.64. Br J Cancer. 1998. PMID: 9472635 Free PMC article.

10

Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.

Reber U, Wüllner U, Trepel M, Baumgart J, Seyfried J, Klockgether T, Dichgans J, Weller M. Reber U, et al. Among authors: weller m. Biochem Pharmacol. 1998 Feb 1;55(3):349-59. doi: 10.1016/s0006-2952(97)00480-2. Biochem Pharmacol. 1998. PMID: 9484802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,706 results

Search Page

Filters